Bullous Dermatosis Associated With Vancomycin Extravasation

被引:14
作者
Bohm, Nicole M. [2 ]
Wong, Jeffrey G. [1 ]
机构
[1] Med Univ S Carolina, Div Gen Internal Med & Geriatr, Dept Med, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Dept Pharm Serv, Charleston, SC 29425 USA
关键词
Vancomycin; Extravasation; Linear IgA bullous dermatosis; Medication side effect; PREVENTION; INJURY;
D O I
10.1097/MAJ.0b013e318237bb47
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cutaneous side effects related to vancomycin therapy have been reported including histamine-related reactions, linear IgA bullous dermatosis, Stevens-Johnson syndrome, maculopapular rash and drug rash with eosinophilia and systemic symptoms. In all instances, these reports were due to the systemic administration of vancomycin and subsequent immunological reactions to the medication. Drug extravasation into soft tissues can result in a variety of clinical outcomes usually related to physiochemical properties of the drug extravasated and its diluents or pharmacologic effects on the vasculature and tissue. The authors report a patient who experienced vancomycin extravasation that resulted in a localized bullous eruption resembling linear IgA bullous dermatosis, a phenomenon not previously described in the literature.
引用
收藏
页码:177 / 179
页数:3
相关论文
共 15 条
[1]   Linear IgA bullous dermatosis associated with vancomycin [J].
Bernstein, EF ;
Schuster, M .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (06) :508-509
[2]   A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis [J].
Billet, Sara E. ;
Kortuem, Kimberly R. ;
Gibson, Lawrence E. ;
el-Azhary, Rokea .
ARCHIVES OF DERMATOLOGY, 2008, 144 (06) :774-778
[3]   Extravasation injury of the upper extremity by intravenous phenytoin [J].
Edwards, JJ ;
Bosek, V .
ANESTHESIA AND ANALGESIA, 2002, 94 (03) :672-673
[4]  
Eid AJ, 2007, CLIN INFECT DIS, V45, P741, DOI [10.1086/520994, 10.1086/520993, 10.1086/520982]
[5]   Extravasation of chemotherapeutic agents: Prevention and treatment [J].
Goolsby, TV ;
Lombardo, FA .
SEMINARS IN ONCOLOGY, 2006, 33 (01) :139-143
[6]  
Institute for Safe Medication Practices, 2006, ISMP MED SAFETY ALER, V11, P1
[7]  
Jones Douglas H., 2004, Journal of the American Osteopathic Association, V104, P157
[8]  
Kähler KC, 2009, J DTSCH DERMATOL GES, V7, P21, DOI 10.1111/j.1610-0387.2008.06752.x
[9]   A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].
NARANJO, CA ;
BUSTO, U ;
SELLERS, EM ;
SANDOR, P ;
RUIZ, I ;
ROBERTS, EA ;
JANECEK, E ;
DOMECQ, C ;
GREENBLATT, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :239-245
[10]   Vancomycin-associated linear IgA bullous dermatosis [J].
Nousari, HC ;
Costarangos, C ;
Anhalt, GJ .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (06) :507-508